Search for:

Home
About
Where we work
News
Strategies
Resources

8 June 2020

Phase I trial of LY-CoV555, an antibody against the COVID-19 spike protein is launched by Eli Lilly and Abcellera. Source

Return to the timeline

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Subscribe to our mailing list

Twitter

RT @peoplesvaccine: Fair access to COVID tests & treatments is crucial, not just for the present, but for potential future treatments like…
10 days ago

Make Medicines Affordable Twitter

Instagram

Make Medicines Affordable campaign challenges abus

Make Medicines Affordable campaign challenges abuses of the #patent system.

Our strategies include making successful legal and technical interventions, in-line with international trade agreements, and working to strengthen patent laws to create long-term change. #MedicineEqualityNow

© Bangkok, Thailand, 2019. © @gemmataylorphoto / Make Medicines Affordable

"We need spread more information around HIV and en

"We need spread more information around HIV and ensure access to affordable treatment". Theo Keborate.

#Botswana, 2021
© Letso Leipego/Majority World/Make Medicines Affordable/2021

#EyesOnPharmaGreed. We have it, do you? #Medicin

#EyesOnPharmaGreed. We have it, do you?

#MedicineEqualityNow and #AbolishTRIPS are the only way out of the COVID-19 pandemics and others to come.

Everyone everywhere has the right to survive. Everyone everywhere has the right to affordable treatments.

@worldtradeorganization could end the pandemics now.

Everyday it passes, the world looses more lives to a disease that already has a vaccine.

Who decides if you get a life-saving vaccine? Th

Who decides if you get a life-saving vaccine?

The world's essential medicines are controlled by a wealthy few, but it's time to take them back. Watch our animation to discover more.

#MedicineEqualityNow #FightToSurvive #AbolishTRIPS

Make Medicines Affordable Instagram

Facebook

ITPC Executive Director, Solange Baptiste, speaking on a CQUIN plenary session entitled "DSD: Where are we now?" highlighted the need to expand the focus of DSD to account for other diseases that affect people living with HIV while considering concurrent major global crises. Resourcing communities is essential to ensuring that meaningful community engagement leads to effective local change for people living with HIV. ... See MoreSee Less

1 day ago ·

ITPC global Facebook

© Copyright ITPC 2022 Cookies Media enquiries Contact us Website by Maraid Design

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage vendors Read more about these purposes

View preferences

{title} {title} {title}